Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
95%
Cross-Sectional Study
63%
Anticoagulant Agent
51%
Warfarin
47%
Polypharmacy
47%
Metformin
47%
Nonalcoholic Fatty Liver
47%
Direct Oral Anticoagulant
47%
Cannabis
47%
Doxorubicin
47%
Cross Sectional Study
47%
Atrial Fibrillation
47%
Diabetes Mellitus
47%
Antiinfective Agent
47%
SARS Coronavirus
47%
Severe Acute Respiratory Syndrome
47%
Drug Absorption
47%
Sodium Glucose Cotransporter 2 Inhibitor
47%
Clinical Pharmacy
47%
Diabetic Complication
35%
Medication Error
34%
Pharmacokinetic
30%
Non Insulin Dependent Diabetes Mellitus
29%
Infection
28%
Hemoglobin A1c
23%
Drug Metabolizing Enzyme
23%
Therapeutic Window
23%
Clinical Pharmacy
23%
Liver Enzyme
15%
Prevalence
13%
Memory Disorder
10%
Coronavirinae
9%
Cohort Study
9%
COVID-19 Vaccine
9%
Antiulcer Agent
8%
Non-Steroidal Anti-Inflammatory Drug
8%
Gastrointestinal Hemorrhage
8%
Malignant Neoplasm
7%
Cognitive Defect
7%
Pharmacodynamics
6%
Dabigatran
6%
Cerebrovascular Accident
6%
Amoxicillin
6%
Clavulanic Acid
6%
Observational Study
6%
Rivaroxaban
6%
Gamma Glutamyltransferase
5%
Liver Disease
5%
Antidiabetic Agent
5%
Alanine Aminotransferase
5%
Medicine and Dentistry
Bariatric Surgery
95%
Roux-en-Y
56%
Sleeve Gastrectomy
51%
Cross Sectional Study
49%
Meta-Analysis
47%
Influenza Vaccine
47%
Stress Ulcer
47%
Antiinfective Agent
47%
Gastroplasty
47%
Laparoscopic Sleeve Gastrectomy
47%
Program Director
47%
Roux-en-Y Gastric Bypass
41%
Medication Error
34%
Gastrointestinal Bleeding
20%
Health Care
11%
Logistic Regression Analysis
11%
Adverse Event
9%
Obesity Medicine
9%
Nonsteroid Antiinflammatory Agent
8%
Antiulcer Agent
8%
Clinical Research
7%
Likert Scale
7%
Amoxicillin
6%
Research Design
6%
Patient Monitoring
5%
Prevalence
5%
Study Participant
5%
Medicare
5%
Diseases
5%
Proportional Hazards Model
5%
Pharmacokinetic
5%
Observational Study
5%
Pharmacodynamics
5%
Cohort Analysis
5%
Hazard Ratio
5%
Nursing and Health Professions
Cross-Sectional Study
100%
Telemedicine
95%
Primary Health Care
52%
Diabetes Mellitus
47%
Odds Ratio
47%
Antiinfective Agent
47%
Patient Compliance
47%
Stress Ulcer
47%
Confidence Interval
47%
Program Director
47%
Clinical Pharmacy
47%
Medication Error
39%
Polypharmacy
19%
Socioeconomic Status
15%
Logistic Regression Analysis
10%
Non Insulin Dependent Diabetes Mellitus
9%
Hemoglobin A1c
9%
Nonsteroid Antiinflammatory Agent
8%
Antiulcer Agent
8%
Gastrointestinal Hemorrhage
8%
Amoxicillin
7%
Clavulanic Acid
7%
Antimicrobial Stewardship
7%
Healthcare System
7%
Research Experience
7%
Practice Guideline
7%
Chi Square Test
5%
